Robots take on throat cancer: early results show promise

NCT ID NCT01257633

Completed Knowledge-focused Sponsor: Centre Hospitalier Universitaire de Nīmes Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how well robot-assisted surgery removes early-stage laryngeal cancer. 54 patients had their tumors removed using a da Vinci robot. The main goal was to see how often the surgery got all the cancer out (clear surgical margins). The study also tracked surgery time and complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Transoral robot-assisted tumor resection using the da Vinci robot
What this could lead to: If successful, this could show that robot-assisted surgery is a reliable way to remove early-stage laryngeal cancer with clear margins.
What could go wrong: This is a small, completed observational study, not a randomized trial. It only measures surgical margins, not long-term survival or recurrence.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLOTTIC LARYNGEAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

glottis carcinoma laryngeal neoplasm supraglottis cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LARYNGEAL NEOPLASMS

Contacts and locations

Show contact details

Locations

CHRU de Toulouse - Hôpital de Rangueil

Toulouse, 31059, France
CHU de Montpellier - Hôpital Gui de Chauliac

Montpellier, 34295, France
CHU de Nîmes - Hôpital Universitaire Carémeau

Nîmes, Gard, 30029, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.